Explore
Glaukos CorpGKOS
$243.13-1.06%24H
GKOS / USDNYSE
Use arrow keys to change the interval
Equity Info
P/E Ratio—
Market Cap$13.98B
EPS-2.95
52 Week Range$87.32 - $255.19
Volume$60.03M
Liquidity Score—
About Glaukos Corp

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, is focused on developing new therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is headquartered in San Clemente, California.

HeadquartersALISO VIEJO, CA

Buy

—
—

Assets

Asset
Glaukos Corporation
rGKOS
Reality Finance
Trending
NVDA
NVIDIA Corporation
$156.353.97%
Details
SPY
SPDR S&P 500 ETF Trust
$740.121.87%
Details
QQQ
Invesco QQQ Trust Series 1
$663.442.42%
Details

Help